References
- Weilburg JB, Rosenbaum JF, Biederman J, Sachs GS, Pollack MH, Kelley K: Fluoxetine added to non-MAOI antidepressants converts nonresponders to re-sponders: A preliminary report. J Clin Psychiatry 50:447–449, 1989
- Schraml F, Benedetti G, Hoyle K, Clayton A: Fluox-etine and nortriptyline combination therapy. Am J Psychiatry 146:1636–1637, 1989
- Fuller RW, Perry KW: Effect of fluoxetine pretreat-ment of plasma and tissue concentrations of desipra-mine in rats. Res Comm Chem Path and Pharm 66:375–384, 1989
- Aranow RB, Hudson JI, Pope HG, Grady TA, Laage TA, Bell IR, Cole JO: Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry 146:911–913, 1989
- Bell IR, Cole JO: Fluoxetine induces elevation of de-sipramine level and exacerbation of geriatric non-psychotic depression. J Clin Psychopharmacol 8:447–448, 1988
- Goodnick PJ: Influence of fluoxetine on plasma levels of desipramine. Am J Psychiatry 146:552, 1989
- Downs JM and Downs AD: Effect of fluoxetine on metabolism of tricyclic antidepressants in the lungs. Am J Psychiatry 146:814–815, 1989
- Guy W (ed): ECDEU Assessment Manual for Psycho-pharmacology, Revised. DHEW Publication No. (ADM) 76–338. Rockville, Maryland, NIMH 1976
- Schweizer E, Rickels K, Amsterdam JD, Fox I, Ruz-zuoli G, Weise C: What constitutes an adequate an-tidepressant trial of fluoxetine? J Clin Psychiatry 51:8-11, 1990
- Baron BM, Ogden A, Seigel BW, Stegeman J, Ursillo RC, Dudley MW: Rapid down regulation of B adre-noreceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol 154:125–134, 1988